Loading news...
Series A funding round for BMS - Autoimmune Disease Drugs Business raising $300M in July 2025
Series A funding round for BMS - Autoimmune Disease Drugs Business raising $300M in July 2025
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$300M
Top Valuation
-
BMS - Autoimmune Disease Drugs Business raised $300M in a Series A round.
The round was announced on 07/01/25.